Quote | Biodesix Inc. (NASDAQ:BDSX)
Last: | $1.57 |
---|---|
Change Percent: | -0.63% |
Open: | $1.61 |
Close: | $1.57 |
High: | $1.62 |
Low: | $1.57 |
Volume: | 120,826 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Biodesix Inc. (NASDAQ:BDSX)
Awarding Excellence in Company Culture Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is honored to announce it has been named to Inc. Magazine’s Best Workplaces list . The ranking is a result of a comprehensive, data-driven measurement pro...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor conferences: William Blair 44 th Annual Growth Stock Conference Presentation and 1x1...
Message Board Posts | Biodesix Inc. (NASDAQ:BDSX)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $BDSX 47% v1,3M c2.00 f81,7M H2.00 ML.97 off 10dma @1.3 | znewcar1 | investorshangout | 11/30/2022 10:29:28 PM |
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE | 1hot toddy | investorshub | 11/22/2022 2:02:28 PM |
Lots if potential but will public offering dilute price? | Leg58 | investorshub | 11/20/2022 5:13:49 AM |
Lots if potential but will public offering dilute price? | Leg58 | investorshub | 11/20/2022 5:13:45 AM |
znewcar1: $BDSX 23% v1,9M c1.42 f42,1M H1.44 ML.96 YL1.07 | znewcar1 | investorshangout | 11/18/2022 5:03:23 AM |
News, Short Squeeze, Breakout and More Instantly...
Awarding Excellence in Company Culture Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is honored to announce it has been named to Inc. Magazine’s Best Workplaces list . The ranking is a result of a comprehensive, data-driven measurement pro...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor conferences: William Blair 44 th Annual Growth Stock Conference Presentation and 1x1...
Data highlights ability of the Nodify XL2 test to identify benign nodules in patients with emphysema Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced that new data will be presented today at the 2024 American Thoracic Society ...